tiprankstipranks
Trending News
More News >
SDI Limited (AU:SDI)
:SDI
Australian Market

SDI Limited (SDI) AI Stock Analysis

Compare
1 Followers

Top Page

AU

SDI Limited

(Sydney:SDI)

Rating:76Outperform
Price Target:
AU$1.00
▲(17.65%Upside)
SDI Limited's overall stock score is driven by its strong financial performance and attractive valuation, with potential for further optimization in ROE and free cash flow conversion. Technical analysis suggests a neutral trend, providing a stable outlook.
Positive Factors
Market Expansion
The company has appointed an experienced Asia sales agent to draft up a strategy to expand into the region.
Product Innovation
Significant research resources have been deployed in their capsule and syringe designs over the years to entrench SDI’s position in the market.
Product Launch Success
Stela reached $1.3m in sales revenue showing strong adoption by distributors and dentists, positioning the product well as the gold standard for amalgam and traditional composite replacement.
Negative Factors
Regional Performance
Strong growth in Europe and Brazil were offset by weakness in the Middle East and Asia and expected decline from amalgam sales.
Sales Decline
SDI provided a trading update with 1H25 sales growth down 1.5% to $51.5m, below our expectation of 7% growth.
Sales Growth Challenges
SDI has provided a trading update, with sales growth down 1.5% to $51.5m.

SDI Limited (SDI) vs. iShares MSCI Australia ETF (EWA)

SDI Limited Business Overview & Revenue Model

Company DescriptionSDI Limited engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia. It provides adhesives, alloys, cement, composites, etchants, glass ionomers, sealants, and tooth desensitizing agents and whitening products, as well as equipment and accessories. The company sells its products through distributors, dealers, and dentists worldwide. SDI Limited was founded in 1972 and is headquartered in Bayswater, Australia.
How the Company Makes MoneySDI Limited generates revenue primarily through the sale of its dental products to dentists, dental clinics, and distributors around the world. The company's revenue streams are largely driven by its core product lines, which include dental restorative materials, whitening systems, and adhesives. SDI also benefits from strategic partnerships and the continuous innovation of its product offerings, which enable it to maintain a competitive edge in the global dental industry. Additionally, the company invests in research and development to enhance product quality and expand its market reach, further contributing to its revenue growth.

SDI Limited Financial Statement Overview

Summary
SDI Limited exhibits strong financial performance with consistent revenue growth, robust margins, and improved cash flow generation. The company's low leverage and strong equity position provide stability, while there is potential to enhance ROE and convert profits more effectively into free cash flow.
Income Statement
82
Very Positive
SDI Limited's income statement shows a strong revenue growth trend with a 3.11% increase from 2023 to 2024. The gross profit margin is robust at 62.07%, indicating effective cost management. Net profit margin improved to 9.37%, reflecting enhanced profitability. The EBIT and EBITDA margins are healthy at 18.33% and 18.85% respectively, showcasing operational efficiency. Overall, the income statement demonstrates solid growth and profitability, though there is room to improve net margins further.
Balance Sheet
75
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.26, suggesting conservative use of leverage. The equity ratio is strong at 66.81%, indicating a solid capital structure. However, the return on equity is moderate at 11.09%, suggesting potential for higher efficiency in generating shareholder returns. Overall, SDI Limited has a stable balance sheet with low leverage but could enhance its ROE.
Cash Flow
78
Positive
SDI Limited's cash flow analysis shows a remarkable improvement in free cash flow, reversing from negative to positive in 2024. The operating cash flow to net income ratio of 1.37 indicates strong cash generation relative to earnings. The free cash flow to net income ratio is 0.39, highlighting room for improvement in converting profits to free cash flow. Overall, cash flow management is positive with significant improvements in free cash flow generation.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
110.50M111.21M107.86M95.15M81.65M67.37M
Gross Profit
69.66M69.04M61.27M53.11M50.25M43.64M
EBIT
18.90M20.39M12.28M10.98M14.82M7.62M
EBITDA
19.73M20.96M15.73M14.76M16.84M9.80M
Net Income Common Stockholders
10.55M10.42M7.06M7.28M8.94M4.24M
Balance SheetCash, Cash Equivalents and Short-Term Investments
6.06M6.28M6.02M7.01M10.56M6.15M
Total Assets
89.71M140.66M133.31M102.07M98.40M84.81M
Total Debt
899.00K24.78M25.60M2.02M1.57M2.63M
Net Debt
-5.16M18.50M19.57M-4.99M-8.99M-3.53M
Total Liabilities
15.00M46.69M45.39M18.34M18.62M11.02M
Stockholders Equity
74.70M93.97M87.92M83.73M79.78M73.79M
Cash FlowFree Cash Flow
7.32M4.03M-21.42M-61.00K8.64M2.32M
Operating Cash Flow
14.10M14.33M13.06M4.27M12.69M7.03M
Investing Cash Flow
-7.54M-8.78M-33.41M-4.25M-3.95M-4.62M
Financing Cash Flow
-8.58M-5.33M19.20M-3.49M-4.18M-2.66M

SDI Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.85
Price Trends
50DMA
0.84
Negative
100DMA
0.87
Negative
200DMA
0.94
Negative
Market Momentum
MACD
<0.01
Negative
RSI
48.48
Neutral
STOCH
51.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SDI, the sentiment is Negative. The current price of 0.85 is above the 20-day moving average (MA) of 0.84, above the 50-day MA of 0.84, and below the 200-day MA of 0.94, indicating a bearish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 48.48 is Neutral, neither overbought nor oversold. The STOCH value of 51.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SDI.

SDI Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AUSDI
76
Outperform
AU$99.25M9.4011.40%4.00%0.82%31.36%
54
Neutral
$5.37B3.35-45.10%2.79%16.77%-0.01%
$2.94B22.016.45%2.46%
$11.46B46.6520.61%1.61%
$76.28B26.6715.38%1.85%
$12.90B54.1321.01%1.45%
AURMD
79
Outperform
AU$56.97B28.3825.23%0.85%10.54%38.69%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:SDI
SDI Limited
0.84
0.07
9.09%
ANSLF
Ansell
18.00
1.34
8.04%
CHEOF
Cochlear
174.16
-37.66
-17.78%
CMXHF
CSL
159.14
-23.30
-12.77%
FSPKF
Fisher & Paykel Healthcare Corporation Limited
20.70
2.92
16.42%
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
38.85
7.46
23.77%

SDI Limited Corporate Events

SDI Limited Announces 1H FY25 Results Release and Investor Call
Feb 6, 2025

SDI Limited is set to release its preliminary financial report for the first half of the fiscal year 2025 on February 27, 2025. The company will host a live investor conference call and webcast on the same day, led by CEO Samantha Cheetham and CFO John Slaviero, to discuss the results and engage with stakeholders. This announcement reflects SDI’s commitment to transparency and stakeholder engagement, potentially impacting its market positioning and investor relations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.